Soluble ST2 to identify the risk of new-onset reduced versus preserved ejection fraction heart failure in community dwelling older adults

被引：0
|
作者：
Defilippi, C. [1 ]
Christenson, R. [1 ]
Gottdiener, J. [1 ]
Seliger, S. [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1283
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] Cardiac specific biomarkers and LVH identify differential risk of new-onset reduced versus preserved ejection fraction heart failure in older adults
    Seliger, S.
    Delemos, J.
    Neeland, I.
    Christenson, R.
    Gottdiener, J.
    Defilippi, C.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 228 - 229
  • [2] Soluble ST2 in Heart Failure With Preserved Ejection Fraction
    AbouEzzeddine, Omar F.
    McKie, Paul M.
    Dunlay, Shannon M.
    Stevens, Susanna R.
    Felker, G. Michael
    Borlaug, Barry A.
    Chen, Horng H.
    Tracy, Russell P.
    Braunwald, Eugene
    Redfield, Margaret M.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (02):
  • [3] ST2 in heart failure with preserved and reduced ejection fraction
    Najjar, Emil
    Faxen, Ulrika Ljung
    Hage, Camilla
    Donal, Erwan
    Daubert, Jean-Claude
    Linde, Cecilia
    Lund, Lars H.
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2019, 53 (01) : 21 - 27
  • [4] Predictors of New-Onset Heart Failure Differences in Preserved Versus Reduced Ejection Fraction
    Ho, Jennifer E.
    Lyass, Asya
    Lee, Douglas S.
    Vasan, Ramachandran S.
    Kannel, William B.
    Larson, Martin G.
    Levy, Daniel
    [J]. CIRCULATION-HEART FAILURE, 2013, 6 (02) : 279 - +
  • [5] ST2 in Heart Failure With Preserved Ejection Fraction
    AbouEzzeddine, Omar F.
    McKie, Paul M.
    Dunlay, Shannon M.
    Stevens, Susanna R.
    Felker, G. M.
    Borlaug, Barry A.
    Chen, Horng H.
    Tracy, Russell P.
    Braunwald, Eugene
    Redfield, Margaret M.
    [J]. CIRCULATION, 2015, 132
  • [6] Sex differences in new-onset heart failure patients with reduced and preserved ejection fraction
    Meyer, S.
    Brouwers, F. P.
    Voors, A. A.
    Hillege, H. L.
    De Boer, R. A.
    Gansevoort, R. T.
    Van der Harst, P.
    Van Veldhuisen, D. J.
    Van Gilst, W. H.
    Van der Meer, P.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1062 - 1062
  • [7] Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
    Kopeva, K. V.
    Teplyakov, A. T.
    Grakova, E. V.
    Ogurkova, O. N.
    Soldatenko, M. V.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 784 - 784
  • [8] The PREVEND risk model for new onset heart failure with preserved and reduced ejection fraction
    Brouwers, F. P. J.
    Cao, Q.
    Van Geel, P. P.
    Voors, A. A.
    Gansevoort, R. T.
    De Boer, R. A.
    Van der Harst, P.
    Van Veldhuisen, D. J.
    Van Gilst, W. H.
    Hillege, J. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 123 - 123
  • [9] Comparing New Onset Heart Failure with Reduced Ejection Fraction and New Onset Heart Failure with Preserved Ejection Fraction: An Epidemiologic Perspective
    Frank P. Brouwers
    Hans L. Hillege
    Wiek H. van Gilst
    Dirk J. van Veldhuisen
    [J]. Current Heart Failure Reports, 2012, 9 (4) : 363 - 368
  • [10] Growth Differentiation Factor 15, ST2 and Natriuretic Peptides in Heart Failure with Preserved versus Reduced Ejection Fraction
    Santhanakrishnan, Rajalakshmi
    Chong, Jenny P.
    Richards, Arthur M.
    Lam, Carolyn S.
    [J]. CIRCULATION, 2011, 124 (21)
12345